Genetic Testing Market Size By Test Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Aug 2019  |  Report ID: GMI2490  |  Authors: Sumant Ugalmugale

Report Format: PDF   |   Pages: 140   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Genetic Testing Market Size was valued at USD 11.8 billion in 2018 and is expected to witness 11.9% CAGR from 2019 to 2025.

Germany Genetic Testing Market Size, By Application, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

Wide range of applications of genetic testing in inherent diseases and oncology will prove beneficial for genetic testing market growth in coming years. Gene diagnosis assists in estimating the probability of developing cancer in an individual. It works by examining specific changes in chromosomes, genes or protein. It also helps healthcare professionals to find exact cause of diseases. Increasing prevalence of chronic diseases and availability of advanced genetic tests will surge its demand.

Growing preference towards of direct-to-consumer (DTC) genetic testing will benefit business growth. DTC genetic testing eliminates healthcare professional’s involvement and are sold directly to consumers through online platforms. It provides comprehensive understanding of individuals genomics and enable them to make necessary changes in lifestyle and dietary habits. This help patients to take early precautions in order to avoid further complexities. These features of DTC tests will augment its demand, thereby fueling the market growth. However, high cost of gene diagnosing tests may hinder the global market growth to certain extent.

Genetic Testing Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 11.8 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 11.9% 2025 Value Projection: 25 Billion (USD)
Pages: 140 Tables, Charts & Figures: 76
Geographies covered (19): U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, South Korea, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, UAE
Segments covered: Test Type, Application and Region
Companies covered (27): andMe, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, Genomic Health, HTG Molecular Diagnostics, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostics, Sequenom, Siemens
Growth Drivers:
  • Growing application of genetic testing in oncology and genetic diseases in North America
  • Technological advancement and availability of new tests
  • Consumer interest in personalized medicine in Europe
  • Physician adoption of genetic tests into clinical care
  • Growing demand for direct-to-consumer genetic testing
Pitfalls & Challenges:
  • High cost of genetic testing
  • Dearth of experienced professionals in developing and underdeveloped countries

Request 15% Free Customization on this Report

Genetic Testing Market, By Test Type

Predictive testing segment was valued more than USD 640 million in 2018 and it will witness lucrative growth over the forecast period. Predictive testing provides information pertaining to complex diseases that an individual may come across in future. Predictive testing has potential to recognise individuals at higher risk of disease. Furthermore, predictive testing will prove beneficial for development of personalized medicines to enhance clinical outcomes. As a result, application of predictive testing in personalized medicines will surge its demand that will exceed segment revenue in coming years.

Pharmacogenomic testing segment of genetic testing is anticipated to witness more than 11% growth over the forecast period. Pharmacogenomic testing assists healthcare professionals to determine the best medication for patients. This test requires minimal amount of blood or saliva to know the suitable and effective treatment. As a result, with the usage of pharmacogenomic testing, adverse effects of medicines can be known and avoided to prevent complexities. These benefits of pharmacogenomic testing will increase its demand over the analysis period.

Genetic Testing Market, By Application

Australia Genetic Testing Market Size, By Application, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF


Genetic disease segment was accounted for around USD 3 billion in 2018 and it is expected to witness robust growth in forthcoming future. Genetic diseases occur due to various factors such as teratogen exposure, inherited and spontaneous mutation, etc. These diseases can be diagnosed through chromosomal, molecular and biochemical gene tests that will assist people in determining the risk of getting genetic diseases. Wide applications of genetic testing in diagnosing detailed family history and possibilities of certain disorders will prove beneficial for segment growth.

Cardiovascular disease segment is anticipated to witness around 13% growth over the forecast period. Substantial growth can be attributed to growing number of patients suffering from cardiovascular diseases. Genetic testing enables to do parallel analysis of numerous genes that contribute to cardiovascular diseases such as cardiomyopathies, arrhythmias and aortopathies. Industry players are developing advanced technologies that allow detection of several genes. For instance, Illumina have developed TruSight Cardio Sequencing Kit that offer
extensive coverage of 174 genes.

Genetic Testing Market, By Region

Europe market size is estimated to witness more than 12% CAGR over the forecast period. Rising number of baby boomers susceptible to chronic diseases will positively influence the demand for genetic testing kits. Moreover, several activities have been undertaken by organizations and regulatory bodies to ensures effective, accurate and superior quality of genetic testing kits. European Commission has provided funding to harmonize the process of the entire genetic testing across the Europe. Objective behind such initiative is to provide superior quality genetic tests that will further give reliable and accurate results, thereby enhancing clinical outcomes. Aforementioned factors will escalate regional growth over the forecast period.

Asia Pacific genetic testing market accounted for around USD 1.5 billion in 2018 and it is estimated to witness substantial growth in forthcoming future. Over the last few decades, changing dietary habits and sedentary lifestyle have created huge patient pool in Asia Pacific region. Moreover, developing healthcare infrastructure and growing disposable income will augment the regional growth over the forecast period.

Asia Pacific Genetic Testing Market Size, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF


Competitive Market Share

Some of the notable players operating in the genetic testing market are Abbott Molecular, Biocartis, Bayer Diagnostics, BioMerieux, Cepheid, Genentech, deCODEme, HTG Molecular Diagnostics, BGI, Celera Genomics, BioHelix, Genomictree, LabCorp Diagnostics, Myriad, Natera, MolecularMD, PacBio, 23andMe, Counsyl, Pathway Genomics,  Roche Diagnostics, IntegraGen, Genomic Health, Qiagen, Siemens, Luminex and  Sequenom. Industry players are adopting strategies such as product launches, collaborations, mergers and acquisitions to sustain market competition.

Recent industry developments:

  • In April 2019, Myriad announced that their product’s EndoPredict test resulted in successful prediction of women who can benefit from adjuvant chemotherapy for HER2-negative breast cancer and ER-positive.  
  • In July 2018, Cepheid received FDA clearance for Xpert Xpress Flu/RSV Test. This genetic testing provides accurate and rapid molecular detection of RSV RNA and influenza A and B viruses. FDA approved products will help company to gain competitive advantage that will exceed its business revenue.

Genetic Testing Industry Background

Genetic testing industry can be traced back to early 1900’s. In early 1900’s, inherited diseases were associated to chromosomes and later in 1950’s scientists started developing genetic tests for disorders such as cystic fibrosis, Down syndrome, and Duchenne muscular dystrophy. Genetic tests initially were used for screening new-born conditions such as phenylketonuria (PKU) in order to treat disease early. Later, several activities were undertaken by industry players to develop genetic tests that could detect various diseases and can be used for clinical studies for drug development. Altogether, there are genetic kits available for more than 2,000 rare and common conditions. There are genetic test types such as predictive and pre-symptomatic genetic, carrier, prenatal, new-born, pre-implantation and pharmacogenetic testing. In coming years, with availability and execution of technologically advanced kits, newer genetic tests will be introduced that will stimulate the market growth. Genetic testing idustry is booming in developed regions and has several opportunities to flourish in developing economies.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X